+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Methylprednisolone in patients with membranous nephropathy and declining renal function



Methylprednisolone in patients with membranous nephropathy and declining renal function



Quarterly Journal of Medicine 65(247): 929-940



Fifteen consecutive patients aged 24 to 70 years, with membranous nephropathy and a progressive decline in renal function, were treated with methylprednisolone, 1 g intravenously daily for five days, followed immediately by a tapering dose of oral prednisolone. Plasma creatinine levels fell by a mean of 46 per cent (range 21-65). In 10 patients the beneficial effect was sustained, but in three it had reversed by six months. In the other two patients the progressive decline of renal function was not influenced. These observations suggest that many patients with membranous nephropathy and declining renal function could benefit from intervention with high dose steroids.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 005892199

Download citation: RISBibTeXText

PMID: 3455548


Related references

Prednisolone therapy in patients with membranous nephropathy and declining renal function. Kidney International 21(4): 668-669, 1982

Immunochemical characterization of cationic immunoglobulin g in patients with membranous nephropathy and declining renal function. Kidney International 28(2): 269, 1985

Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. New England Journal of Medicine 327(9): 599-603, 1992

Membranous nephropathy in young patients with normal renal function. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 678A, 2002

A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. Journal of the American Society of Nephrology 9(3): 444-450, 1998

Ameliorating effects of conventional therapy on declining renal function in patients with diabetic nephropathy. Tokai Journal of Experimental and Clinical Medicine 16(3-4): 187-192, 1991

M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clinical Journal of the American Society of Nephrology 9(11): 1883-1890, 2015

The Usefulness of Phospholipase A2 Receptor and IgG4 Detection in Differentiation Primary Membranous Nephropathy From Secondary Membranous Nephropathy in Renal Biopsy. Applied Immunohistochemistry and Molecular Morphology 26(8): 591-598, 2017

Membranous nephropathy with chronic renal failure. Partial native renal function recovery after unsuccessful renal transplant. Archives of Internal Medicine 140(3): 437-438, 1980

Cyclosporine versus conservative therapy in patients with idiopathic membranous nephropathy and deteriorating renal function Results of the CYCLOMEN trial. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 95A, 2000

Preserving renal function in patients with membranous nephropathy: daily oral chlorambucil compared with intermittent monthly pulses of cyclophosphamide. Annals of Internal Medicine 121(5): 328-333, 1994

Localization of C3d in renal tissues of patients with membranous nephropathy and IgA nephropathy. Nihon Jinzo Gakkai Shi 29(9): 1161-1165, 1987

Evaluation of the staining findings of immunofluorescence in unfixed or fixed renal biopsy specimens from patients with IgA nephropathy and membranous nephropathy. Acta Pathologica Japonica 35(2): 315-321, 1985

Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function. Journal of Nephrology 27(3): 307-316, 2015

Evaluation of the staining findings of immunofluorescence in unfixed or fixed renal biopsy specimens from patients with immunoglobulin a nephropathy and membranous nephropathy. Acta Pathologica Japonica 35(2): 315-322, 1985